PA-BOOMI
Boomi™, the intelligent integration and automation leader, today announced an enhanced version of Boomi for SAP to help accelerate the migration of SAP Business Warehouse (SAP BW) customers to SAP Datasphere. By leveraging Amazon Web Services (AWS), Boomi aims to address the critical challenge of enterprise customers who need to transition to SAP Datasphere, and unlock the full potential of their business data in a cost-effective and streamlined way.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240509748233/en/
Boomi to Simplify and Accelerate the Move to SAP Datasphere (Graphic: Business Wire)
Addressing a Critical Challenge in Data Migration
With mainstream support ending for SAP BW coming at the close of 2027, SAP BW customers are encouraged to migrate to SAP Datasphere, which will enable business transformation by delivering seamless, scalable access to business-critical data. However, the move to SAP Datasphere requires significant investment and substantial effort from highly-skilled individuals.
Boomi for SAP accelerates the transition to SAP Datasphere on AWS through Boomi’s low-code, integration platform. Customers can simply log into the Boomi Enterprise Platform and leverage a pre-built accelerator specifically designed to speed the migration and integration of data into SAP Datasphere on AWS.
“SAP Datasphere is SAP's foundation for a business data fabric, but many companies with earlier versions of SAP BW are overburdened with the cost-prohibitive, time-consuming, and resource-intensive process of migrating to it,” said Steve Lucas, CEO at Boomi. “This new collaboration leverages Boomi’s expertise in intelligent integration and automation, along with AWS services, to provide a lighter, faster, more cost-effective way for organizations to transition to SAP Datasphere, getting the most out of their SAP investments and their data.”
Key benefits of Boomi for SAP include:
- Avoid costly SAP BW version upgrades and the need for a staging area, resulting in time and cost savings
- The ability to select which SAP BW Queries and BW InfoProviders to move to Datasphere
- Efficient data tiering to SAP Datasphere and Amazon Redshift, a fully managed, petabyte-scale data warehouse service, enabling businesses to move less frequently used data to more affordable cloud storage tiers
- Faster integration of third-party data into SAP Datasphere at a lower cost
- Better data preparation for more efficient use of data analytics and artificial intelligence (AI)
- A smooth procurement process in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on AWS
“The ability to aggregate diverse datasets is emerging as a critical advantage as organizations recognize the pivotal role of AI in their operations,” said Matt Aslett, director of research at Ventana Research, part of ISG. “Data preparation and integration is imperative to ensuring more efficient utilization of data analytics and AI, and the acceleration of business outcomes through data-driven decision-making.”
“Working with AWS reinforces Boomi’s commitment to delivering a practical path to enterprise analytics and AI, beginning with a robust data foundation,” said Ed Macosky, Chief Product and Technology Officer at Boomi. “With the Boomi Enterprise Platform, organizations can achieve a more flexible, scalable, and connected ecosystem to drive innovation, future-proof their IT investments, reduce total cost of ownership, and enhance business outcomes.”
Availability
Boomi for SAP is available in AWS Marketplace, and on the Boomi Enterprise Platform.
Additional Resources
- Find Boomi in AWS Marketplace
- Explore Boomi Recipes and Accelerators for SAP in the Discover Catalog
- Explore the Boomiverse Community
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240509748233/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 01:00:00 CET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 22:30:00 CET | Press release
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041 Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the corne
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 22:05:00 CET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 20:00:00 CET | Press release
Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain an
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 19:32:00 CET | Press release
First Marketing Authorization granted in France for the treatment of ricin poisoning, one of the most toxic natural substances in the world and a recognized priority biological threat. Ricimed® addresses a previously unmet medical need in the management of severe and potentially fatal ricin intoxications.Supported by the French Ministry of the Armed Forces and Veterans Affairs (the Directorate General of Armaments and the French Military Health Service), the development of Ricimed® illustrates Fabentech’s transition to a new scale and, with recent support from the European HERA Invest program, reinforces its positioning as a reference player in medical countermeasures against biological threats, serving both civilian and military markets. Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release featur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom